FDA Clearance for Monteris Medical Ablation System
Today’s Medical Developments reports that Monteris Medical‘s second generation MRI-guided ablation device, the “NeuroBlate System,” has just received FDA 510(k) clearance.
According to the press release, the NeuroBlate System combines updated, active MRI visualization and a surgical laser to selectively ablate diseased brain tissue. Monteris Medical’s first generation system has been available in U.S. hospitals since 2010. Regarding its new system, John Schellhorn, President and CEO of Monteris Medical, states that:
Monteris invested significant resources to develop a laser ablation system that is faster and adapts to contemporary clinical workflow. The NeuroBlate System provides neurosurgeons controlled, three-dimensional ablation via a powerful software platform. It supports surgical decision making during brain operations as well as providing post-procedure confirmation of the effects of the thermal therapy.
The press release also indicates that the Cleveland Clinic will soon be adopting Monteris Medical’s second generation NeuroBlate System to treat patients who seek minimally invasive options or are not candidates for traditional surgery.
AngioDynamics Purchases Ablation Technology
AngioDynamics is going ahead with the purchase of microwave ablation technology from Microsulis Medical, Poststar reports. According to the story, AngioDynamics plans to incorporate the microwave ablation technology into its own technology “in an all-in-one device that offers a full spectrum of ablation technologies on the same cart, called the ‘total ablation solution.’” The story summarizes the terms of the deal:
AngioDynamics will pay $10 million cash initially, to be followed by a $5 million cash payment at the end of 2013, according to a statement issued Wednesday. The Latham-based firm will also assume up to $1 million of liabilities on Microsulis’ books.
According to the story, AngioDynamics President and CEO Joseph DeVivo said that he expects the Microsulis technology to improve a thermal ablation business that generated $23 million in 2012.
Share